How to accelerate small molecule API development

In as little as 14 weeks from receiving your small molecule API, you can have your Phase I drug product manufactured, labelled, packaged and delivered to the clinic. That’s 1 month faster than most standard timelines and includes a one-month stability study.

Plus, you now have access to five dosage forms:

  • Blend in bottle
  • API in bottle
  • Softgel capsules
  • Blend in capsule
  • API in capsule

Benefits of our small molecule & oral solid dose Quick to Clinic™

  • Speed is important, but consistent high quality is a must: Our regulatory and RFTIT/OTD (Right First Time in Full/ On-Time Delivery) performance are second to none.
  • All the data you need: With 1-month stability studies, you’ll have the data you need to make informed proof of concept decisions and to complete your regulatory submissions.
  • Unmatched capabilities and experience: Meet the unique needs of your molecule and business with expansive resources and the experience of thousands of projects.
  • Lay the foundation for commercial success: You’ll establish a clear path that could take you all the way to commercial success. Reach your milestones faster. Never compromise quality.

Want to talk about your next early development project?

Related Sites

Additional Resources